Where is Arivale located?

Arivale is headquartered in Seattle, United States.

Is Arivale a funded company?

Arivale is a funded company, having raised a total of $53.6M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round.

When was the latest funding round of Arivale?

Arivale's latest funding was a $***** Series C round on Jun 13, 2017, with participation from 0 investor. Its primary sector is Healthcare Booking Platforms. In United States, the Healthcare Booking Platforms sector has seen $931M in funding in 2026 to date.

Where does Arivale rank among its competitors?

Arivale ranks 8th amongst 102 active competitors, of which 20 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Genomind, which secured $400K in Feb, 2025.

Who are the top competitors of Arivale?

Arivale's top competitors include Helix, MyOme and InformedDNA. Among them, Genomind secured the most recent funding round in February, 2025.

Arivale - 2026 Company Profile, Team, Funding & Competitors

Company Details

Arivale is a bioscience company which does various direct-to-consumer tests of consumer's genome, blood and saliva, gut microbiome, and lifestyle. They analyze the consumer's genome, clinical chemistries, lifestyle, and microbiome to produce fitness and nutritional advice tailored to individuals. Lee Hood,biotech pioneer, is one of the founding members.

Website: arivale.com
Social

Key Metrics

Founded Year

2014

Location

Seattle, United States

Stage

Series C

Total Funding

$53.6M in 3 rounds

Latest Funding Round

Series C, Jun 13, 2017, $*****

Investors

Maveron & 4 more

Ranked

8^th among 102 active competitors

Similar Companies

MyHeritage & 503 more

View Arivale's full profile

Arivale is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ARIVALE INC. CIN: 463801506 , Belgium, Active	Sep 08, 2013	-	-	-

Arivale has raised a total funding of $53.6M over 3 rounds. Arivale has 5 institutional investors.

Here is the list of recent funding rounds of Arivale:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 13, 2017	8407861	Series C	6200947	9727124	1591775	4479972
Jul 14, 2015	1876025	Series B	6471704	1007654	Maveron	Polaris Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Arivale's funding rounds and investors

The founders of Arivale are Leroy Hood, Nathan Price and Clayton Lewis.

Here are the details of Arivale's key team members:

Leroy Hood: Co-Founder of Arivale and founder of 1 other company.
Nathan Price: Co-Founder and Board of Directors of Arivale.
Clayton Lewis: Co-Founder & CEO of Arivale.

View details of Arivale's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Arivale include Helix, MyOme and InformedDNA. Here is the list of Top 10 competitors of Arivale, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
2nd	MyOme 2017, San Carlos (United States), Series B	Provider of a platform for gene analysis to determine genetic diseases and drug response	$36M	Healthcare Ventures, Foresite Capital & 1 others	60/100
3rd	InformedDNA 2007, St Petersburg (United States), Series A	Provider of network of genetics experts to help patients and providers	$19.2M	Frist Cressey Ventures, NovaQuest Capital Management ... & 5 others	57/100
4th	Genomind 2009, King Of Prussia (United States), Series C	Developer of genetic tests for personalised medicines to enhance mental health treatment	$64.4M	Claritas Capital, SVB & 1 others	56/100
5th	Counsyl 2007, San Francisco (United States), Acquired	DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening	$113M	Perceptive Advisors, Y Ventures & 14 others	54/100
6th	Digbi Health 2018, Mountain View (United States), Series A	Provider of personalized healthcare on basis of DNA testing	$8.5M	Accel, Ocean Azul Partners & 9 others	48/100
7th	GB HealthWatch 2012, San Diego (United States), Series B	Online platform offering personalized nutrition plans	$9.78M	Trinity Power, Rotating Boulder Fund	44/100
8th	Arivale 2014, Seattle (United States), Series C	Provider of direct-to-consumer genetic testing.	$53.6M	New York Life Ventures, Maveron & 3 others	44/100
9th	Recombine 2011, New York City (United States), Acquired	Genetic testing services	$12.1M	FirstMark, Vast Ventures & 3 others	44/100
10th	JScreen 2013, Chamblee (United States), Unfunded	Provider of genetic testing services	-	-	43/100